ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023

In person

From 10 to 13 June Michael Nyman attended ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium in Boston. The conference was co-organized as a collaboration between the ACS (American Chemical Society), MEDI (Division of Medicinal Chemistry) and the EFMC (European Federation for Medicinal Chemistry and Chemical Biology).

The meeting attracted a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.